- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05275621
Virtual Reality as a Substitute to Pharmacological Sedation During PICC Placement in Pediatric Patients (ViVA)
Virtual Reality for Vascular Access: a Multicenter Feasibility Study
In pediatric patients Peripherally Inserted Central Catheters (PICC) insertion requires pharmacological sedation provided by an anesthesiologist, which poses a certain degree of risks. In enrolled subjects, PICC insertion is tried without drug sedation, using an immersive virtual reality experience as a distraction technique. If the subjects is not able to keep still or if pain levels are too high, the virtual reality attempt is stopped and standard drug sedation is provided by a pediatric anesthesiologist.
Aim of study is to evaluate the feasibility of the PICC insertion procedure using the virtual reality distraction technique. The investigators hypothesize that this could avoid the need for drug sedation, reducing sedation-related risks and costs and reduce anxiety and pain related to the procedure.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A PICC is a central intravenous catheter inserted through a peripheral vein of the upper arm. In pediatric subjects, the insertion usually requires pharmacological sedation because of the anxiety and the pain experienced by the children during the procedure. Sedation inevitably poses a certain risk, particularly of airway obstruction, respiratory drive reduction en hemodynamic instability. Finally, costs are sensibly higher when sedation is required, since, besides the need for drugs and devices (e.g. for monitoring and airway management), an experienced pediatric anesthesiologist and a nurse are needed for providing sedation.
The investigators hypothesize that the application of virtual reality to children undergoing PICC placement, could avoid the need for drug sedation. This would result in a reduction in anxiety and pain related to the procedure and a potential reduction in costs. Moreover any possible adverse event related to pharmacological sedation would be avoided.
The material used for providing the virtual reality experience consist of a commercially available virtual reality headset (Oculus Quest 2 by Facebook Technologies ltd) and a dedicated software called "TOMMI" (developed by Softcare Studios Srl). Subjects find themselves in a virtual environment where they can play different games. The game which was chosen is called "drums", optimized for enhanced sensorimotor engagement and distraction from acute sensations such as pain. In this game subjects see three different drums they can beat with a "magic wand" they can control by moving the handheld controller. Geometric shapes in different colors fall from above indicating which drum to beat and at which time.
This game was chosen for several reasons: it can be played for sufficient time without getting excessively boring or tiring (the procedure usually lasts about half an hour); it can be easily played both by younger and older children; it does not require wide movements either of the head or of the upper limb holding the controller, and the opposite upper limb isn't involved in any way. Thus, distracting or even dangerous movements of the subject can be avoided, ensuring the successful completion of the procedure.
Subjects will be enrolled by the investigators in each participating center according to the inclusion and exclusion criteria. To participate informed consent has to be acquired in written form from both the caregivers and, if able to do so, also by the subjects.
Before the procedure multiple variables will be recorded to draw a baseline of each enrolled subject. These will include age, sex, BMI, previous experiences of sedation and of venipuncture and a psychological and behavioral profile using a self-administered questionnaire for caregivers (Child Behaviour Checklist - Achenbach ASEBA).
At the start of the procedure the Investigators will explain to the subject the use of the Virtual Reality viewer and will help him in positioning it. Patients will be monitored with continuous ECG and SpO2. All PICC placements will be carried out by trained and experienced implanter, in a dedicated room and under full barrier precautions. A pediatric anesthesiologist will always be available on site.
While arranging the sterile field, and at least for five minutes, the implanter will let the patient get fully immersed in the virtual environment. Meanwhile, the implanter will check that the child has correctly understood how to play the game.
In each patient, the site of insertion will be chosen after proper echographic evaluation of the vascular anatomy following the RaPeVA protocol as recommended by the Italian Vascular Access Society (IVAS). Entry site will be chosen in the middle third of the upper arm or in the "green zone" after the Zone Insertion Method™ by Robert Dawson. Venipuncture will be performed under ultrasound guidance and the catheter will be placed using a modified Seldinger technique over a tearaway introducer. Before introducing the dilator, the provider will inject the area with a local anesthetic and performed a small skin incision with a scalpel. Tip guidance and location was achieved through continuous intracavitary ECG.
Standard procedural sedation will be provided for those who won't tolerate the procedure using only the Virtual Reality immersion. No kind of active or passive restraint will be enforced during the whole procedure, the patients will be required to hold still for the whole time just by themselves.
Data will be analyzed with the R software in its latest version - Copyright (C) 2021 The R Foundation for Statistical Computing Platform: R Core Team (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/.
Continuous data will be reported as mean and standard deviation, categorical as number (percentage).
The investigators consider the accomplishment of the PICC placement procedure as the primary endpoint of our study (a dichotomous N/Y variable).
The procedure with the virtual reality is expected to be successful in the majority of all cases. Hence, in calculating the sample size (without finite population correction), the investigators consider an expected proportion of accomplishment of 0.95 with a precision (half width of the 95 percent confidence interval) of 0.04. This yields a sample size of 120 patients.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Marco Gemma, MD
- Phone Number: +39 0263632414
- Email: marco.gemma@asst-fbf-sacco.it
Study Locations
-
-
-
Napoli, Italy
- AORN Pausilipon
-
Contact:
- Federica Pitta
- Phone Number: 081 2205111
- Email: santobonopausilipon@pec.it
-
Torino, Italy, 10126
- Regina Margherita Hospital
-
Contact:
- Giorgio Ivani, MD
- Phone Number: +39 0113135937
- Email: gioivani@libero.it
-
-
BS
-
Brescia, BS, Italy, 25123
- Spedali Civili di Brescia
-
Contact:
- Stefano Benvenuti, MD
- Phone Number: +39 030996201
-
-
GE
-
Genova, GE, Italy
- Ospedale Pediatrico Istituto Gianna Gaslini
-
Contact:
- Michele Wolfler, MD
- Phone Number: +39 010 56362445
- Email: segranestesia@gaslini.org
-
-
MI
-
Milano, MI, Italy, 20100
- Ospedale dei Bambini "Vittore Buzzi"
-
Milano, MI, Italy, 20121
- Fatebenefratelli Hospital
-
Contact:
- Marco Gemma, MD
- Phone Number: +39 0263632414
- Email: gemma.marco@hsr.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged between 7 and 14 years old
- Indication for Vascular Access Device placement with the need for sedation
- Signed informed consent form by the subject's caregivers (commonly both parents)
Exclusion Criteria:
- Inability to fill in the rating scales
- Inability to experience Virtual Reality with TOMMI (e.g., eye diseases)
- Presence of disease that produces complete immobility
- Refusal to sign informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Subjects requiring PICC
Subjects requiring a PICC.
Positioning is first tried under Virtual Reality distraction.
If failure (movements or discomfort) standard procedural sedation is applied.
No kind of physical restraint is allowed.
|
A Virtual Reality game is provided through a headset.
Subjects play in a virtual environment.
Positioning of the headset occurs before starting the procedure and is maintained throughout the procedure.
The headset used will be "Oculus Rift 2 by Facebook Tech.
ltd.".
The software is designed specifically for the purpose by Softcare Studios.
The "game" played is called "Drums".
A PICC is inserted under ultrasound guidance through a modified Seldinger technique in a deep vein of the upper arm.
The skin is infiltrated with 0.5-1ml 2% lidocaine before dilation of the skin.
Tip guidance and positioning is achieved through intracavitary ECG.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in baseline Pain assessed by the Wong-Baker FACES Scale
Time Frame: Baseline and Five minutes after the procedure has been completed
|
The Wong-Baker FACES Scale is a validated scale used to assess the experienced pain in subjects from three years of age.
It consists of six different faces: the first represents no pain at all and is described by the words "No Hurt" and the last one represents a pain score of "10 out of 10" on a numeric rating scale, and indicates "hurts worst."
|
Baseline and Five minutes after the procedure has been completed
|
Change in baseline Anxiety assessed by a numeric rating scale
Time Frame: Baseline and Five minutes after the procedure has been completed
|
Anxiety is assessed through a numeric rating scale ranging from zero representing no anxiety at all, up to ten representing the worst anxiety level.
|
Baseline and Five minutes after the procedure has been completed
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of the procedure
Time Frame: During the procedure
|
time for catheter positioning is measured
|
During the procedure
|
Subject's satisfaction
Time Frame: through study completion, an average of three months
|
Subject's satisfaction is measured through a numeric rate scale from 0 to 10 with 0 indicating extreme discomfort and 10 indicating absolute satisfaction.
|
through study completion, an average of three months
|
Staff satisfaction
Time Frame: After study completion, expected six months
|
Staff satisfaction on the procedure is evaluated through a numeric rate scale from 0, indicating not satisfied at all, to 10, very satisfied.
|
After study completion, expected six months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marco Gemma, MD, ASST Fatebenefratelli Sacco
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2021/ST/291
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Procedural Anxiety
-
Amsterdam UMC, location VUmcNot yet recruitingIVF | Procedural Pain | Procedural AnxietyNetherlands
-
Grigore T. Popa University of Medicine and PharmacyRomanian AcademyNot yet recruitingProcedural Pain | Procedural AnxietyRomania
-
Aynur Aytekin OzdemirCompletedProcedural Pain | Procedural AnxietyTurkey
-
C.R.Darnall Army Medical CenterCompletedProcedural Pain | Procedural AnxietyUnited States
-
Hannover Medical SchoolCompletedPediatric Cancer | Procedural Pain | Procedural AnxietyGermany
-
Istanbul Medeniyet UniversityCompletedProcedural Pain | Procedural AnxietyTurkey
-
MetroHealth Medical CenterCompletedPain | Low Back Pain | Procedural Pain | Procedural AnxietyUnited States
-
Ulku GunesCompletedProcedural Pain | Procedural AnxietyTurkey
-
Akdeniz UniversityActive, not recruitingFear | Child, Only | Procedural Pain | Procedural AnxietyTurkey
-
Akdeniz UniversityActive, not recruitingFear | Child, Only | Procedural Pain | Procedural AnxietyTurkey
Clinical Trials on Virtual Reality
-
Institut National de la Santé Et de la Recherche...Not yet recruitingSchizophrenia | Bipolar Disorder
-
Eskisehir Osmangazi UniversityNot yet recruiting
-
The University of Hong KongRecruiting
-
Universidad Rey Juan CarlosCompleted
-
University of PennsylvaniaNot yet recruitingEnd Stage Kidney Disease
-
National University of MalaysiaRecruitingPleural EffusionMalaysia
-
Stanford UniversityTerminatedConversion Disorder | Non-epileptic Seizures | Functional Neurological Disorder | Functional Movement Disorder | Psychogenic Movement DisorderUnited States
-
University of WashingtonNational Institutes of Health (NIH); University of Texas; National Institute...Completed
-
Centre Hospitalier Universitaire de Saint EtienneInstitut de Cancérologie de la Loire; Gustave Roussy, Cancer Campus, Grand... and other collaboratorsTerminated
-
Hacettepe UniversityRecruitingGonarthrosis; PrimaryTurkey